Hit enter to search or ESC to close
YOZMA GROUP KOREAYOZMA GROUP KOREA
Menu
  • About
    • Overview
    • Yozma Story
    • Team
  • Business
    • Investment
    • Business Development
    • Tech Transfer
  • Portfolio
  • Newsroom
    • News
    • Video
  • Contact
  • English
    • Korean
  • About
    • Overview
    • Yozma Story
    • Team
  • Business
    • Investment
    • Business Development
    • Tech Transfer
  • Portfolio
  • Newsroom
    • News
    • Video
  • Contact
  • English
    • Korean
Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology
News

Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology

By yozmakorea2023-07-28July 31st, 2023No Comments

Home » Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology

Selvas Healthcare-funded UltraSight receives FDA clearance for AI cardiac ultrasound technology

https://www.mk.co.kr/news/business/10795693

Tags:

ultrasightselvashealthcareFDA
  • Previous PostMaeil Business Newspaper Interview - Moshe Ben-bassat, Chairman of Plataine

  • Next PostFDA Grants Clearance for UltraSight's AI cardiac ultrasound technology

서울 오피스 / Seoul Office
서울시 강남구 봉은사로 457 S&C TOWER 9층
9F, S&C TOWER, 457, Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea
t. +82 2 6949 5350
e. [email protected]

Israel Office
2 Ben Gurion way, BSR 1 building fl 14, Ramat Gan, Israel
e. [email protected]

Family Site
Yozma Group Israel HQ
Yozma Campus (PR/Marketing)

  • Privacy Policy

© 2026 Yozma Group Korea.